RSV (Respiratory Syncytial Virus)
Participate in clinical trials for RSV (Respiratory Syncytial Virus) to support vital research aimed at developing innovative treatments and improving care. Your involvement helps enhance outcomes and quality of life for individuals affected by RSV. Join us today to make a meaningful difference!
Showing all 4 results
-
Device for COVID, Flu and RSV
Help us improve understanding of respiratory infections like COVID-19, Flu A, Flu B, and RSV. Criteria & Qualifications: • Must have symptoms such as cough, fatigue, or sore throat that started within the last 7 days. • Must not currently have nasal trauma (e.g., nosebleeds) or have used nasal rinses recently. • Must not be undergoing treatment for COVID-19 or flu within the past 14 days. Compensation: Contact us for more information.
Device for COVID, Flu and RSV
Read more -
Pediatric Respiratory Syncytial Virus (RSV)
We’re conducting a study to explore a new option for children with respiratory syncytial virus (RSV). This research aims to better understand how it can support recovery and overall health. Criteria & Qualifications: • Must be under 18 years old. • Diagnosed with RSV. • May have health factors like certain medical conditions. Compensation: Contact us for more information
Pediatric Respiratory Syncytial Virus (RSV)
Read more -
Respiratory Syncytial Virus (RSV)
We’re conducting a study to evaluate a new treatment for adults with acute respiratory syncytial virus (RSV) infection. The goal is to understand how this treatment may help reduce symptoms faster and improve health outcomes. Criteria & Qualifications:
• Must be 18 years or older.
• Diagnosed with acute RSV infection.
• Exhibits risk factors such as age 60+, chronic lung diseases, or cardiovascular conditions.
Compensation: Contact us for more informationRespiratory Syncytial Virus (RSV)
Read more -
Respiratory Syncytial Virus (RSV) Study
Participate in an RSV vaccine study to combat lung infections. Help us understand vaccine effects in diverse health conditions. Eligibility criteria apply. Criteria & Qualifications: • Must be 18 years or older and diagnosed with RSV within the last 5 days. • Experiencing new or worsening symptoms like cough or shortness of breath within 5 days before randomization. • Either aged 65+, or have chronic lung disease, heart failure, or an immunosuppressive condition. Compensation: Contact us for more information
Respiratory Syncytial Virus (RSV) Study
Read more